Zobrazeno 1 - 10 of 17 pro vyhledávání: '"Errico MC"'
1
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma
Autor: Felli N, Felicetti F, Lustri AM, Errico MC, Bottero L, Cannistraci A, De Feo A, Petrini M, Pedini F, Biffoni M, Alvino E, Negrini M, Ferracin M, Mattia G, Carè A. PLoS One. 2013, 8(2):e56824. doi: 10.1371/journal.pone.0056824. Epub 2013 Feb 21. PMID: 23437250 [PubMed - in process]
Publikováno v: PloS one 8 (2013): E56824. doi:10.1371/journal.pone.0056824.
info:cnr-pdr/source/autori:Felli N, Felicetti F, Lustri AM, Errico MC, Bottero L, Cannistraci A, De Feo A, Petrini M, Pedini F, Biffoni M, Alvino E, Negrini M, Ferracin M, Mattia G, Carè A. PLoS One. 2013;8(2):e56824. doi: 10.1371%2Fjournal.pone.0056824. Epub 2013 Feb 21. PMID: 23437250 [PubMed-in process]/titolo:miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma./doi:10.1371%2Fjournal.pone.0056824./rivista:PloS one/anno:2013/pagina_da:E56824/pagina_a:/intervallo_pagine:E56824/volume:8
The abnormal expression of several microRNAs has a causal role in tumorigenesis with either antineoplastic or oncogenic functions. Here we demonstrated that miR-126 and miR-126* play a tumor suppressor role in human melanoma through the direct or ind
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::c208bd9d836523105f13fd338b73fd55
Zobrazit plný text záznamu
3
The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway
Autor: Alessandra Boe, Gianfranco Mattia, Hardev Pandha, Lisabianca Bottero, Mario P. Colombo, Claudio Tripodo, Marina Petrini, M. Cristina Errico, Richard Morgan, Maria Bellenghi, Marco Calvaruso, Alessandra Carè, Nadia Felli, Federica Felicetti
Publikováno v: International Journal of Cancer. Journal International du Cancer
Cutaneous melanoma is the fastest increasing cancer worldwide. Although several molecular abnormalities have been associated with melanoma progression, the underlying mechanisms are still largely unknown and few targeted therapies are under evaluatio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfaa80e75726a513720cbccf5c10e206
http://hdl.handle.net/10447/98737
Zobrazit plný text záznamu
4
Akademický článek
An analysis of the strategic plan development processes of major public organisations funding health research in nine high-income countries worldwide.
Autor: Morciano C; Research Coordination and Support Service, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161, Rome, Italy. cristina.morciano@iss.it., Errico MC; Research Coordination and Support Service, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161, Rome, Italy., Faralli C; National Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanità, Rome, Italy., Minghetti L; Research Coordination and Support Service, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161, Rome, Italy.
Publikováno v: Health research policy and systems [Health Res Policy Syst] 2020 Sep 18; Vol. 18 (1), pp. 106. Date of Electronic Publication: 2020 Sep 18.
Zobrazit plný text záznamu
5
Akademický článek
[The biological resources and molecule archives organization: turn a need into an opportunity for the Smart Specialization Strategy of the Lazio region.]
Autor: Bravo E; Istituto Superiore di Sanità, Roma., Franchin T; IRCCS Ospedale Pediatrico Bambino Gesù, Roma., Santoro F; Istituto Superiore di Sanità, Roma., Conti L; IRCCS Istituto Nazionale Tumori Regina Elena, Roma., Carrara S; IRCCS INMI Lazzaro Spallanzani, Roma., Marino M; IRCCS Istituto Nazionale Tumori Regina Elena, Roma., Di Caro A; IRCCS INMI Lazzaro Spallanzani, Roma., Cigliana G; IRCCS Istituto Nazionale Tumori Regina Elena, Roma., Mandoj C; IRCCS Istituto Nazionale Tumori Regina Elena, Roma., Baselice S; IRCCS Istituto Nazionale Tumori Regina Elena, Roma., Daniele N; Cryolab Università di Roma Tor Vergata., Giampaoli S; Istituto Superiore di Sanità, Roma., Quintarelli C; IRCCS Ospedale Pediatrico Bambino Gesù, Roma., Salerno M; Consorzio Collezione Nazionale dei Composti Chimici e Centro Screening (CNCCS), Pomezia (Roma)., Zinno F; Azienda Ospedaliera di Cosenza, Servizio di Immunoematologia e Medicina Trasfusionale, Cosenza., Russo G; Laboratorio di Oncologia Molecolare, Istituto Dermopatico dell'Immacolata, Roma., Errico MC; Istituto Superiore di Sanità, Roma., Minghetti L; Istituto Superiore di Sanità, Roma., Ricciardi W; Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Roma., Napolitano M; Istituto Superiore di Sanità, Roma.
Publikováno v: Recenti progressi in medicina [Recenti Prog Med] 2019 Feb; Vol. 110 (2), pp. 68-74.
Zobrazit plný text záznamu
6
Akademický článek
AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression.
Autor: Felli N; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Errico MC; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Pedini F; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Petrini M; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Puglisi R; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Bellenghi M; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Boe A; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Felicetti F; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Mattia G; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., De Feo A; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Bottero L; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Tripodo C; Department of Health Sciences, University of Palermo, Palermo, Italy., Carè A; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Publikováno v: Oncogene [Oncogene] 2016 Jun 09; Vol. 35 (23), pp. 3016-26. Date of Electronic Publication: 2015 Oct 05.
Zobrazit plný text záznamu
7
Akademický článek
The Widening Sphere of Influence of HOXB7 in Solid Tumors.
Autor: Errico MC; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Jin K; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Sukumar S; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. saras@jhmi.edu alessandra.care@iss.it., Carè A; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. saras@jhmi.edu alessandra.care@iss.it.
Publikováno v: Cancer research [Cancer Res] 2016 May 15; Vol. 76 (10), pp. 2857-62. Date of Electronic Publication: 2016 Apr 20.
Zobrazit plný text záznamu
8
Akademický článek
Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma.
Autor: Felicetti F; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy. federica.felicetti@iss.it., De Feo A; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy. alessandra.defeo@guest.iss.it., Coscia C; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy. carolina_coscia@hotmail.com., Puglisi R; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy. rossella.puglisi@iss.it., Pedini F; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy. francesca.pedini@iss.it., Pasquini L; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy. luca.pasquini@guest.iss., Bellenghi M; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy. maria.bellenghi@guest.iss.it., Errico MC; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy. mariacristina.errico@iss.it., Pagani E; Laboratory of Molecular Oncology, Istituto Dermopatico DELL'IMMACOLATA-IRCCS, 00167, Rome, Italy. anelepag@libero.it., Carè A; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy. alessandra.care@iss.it.
Publikováno v: Journal of translational medicine [J Transl Med] 2016 Feb 24; Vol. 14, pp. 56. Date of Electronic Publication: 2016 Feb 24.
Zobrazit plný text záznamu
9
Akademický článek
SCD5-induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin B.
Autor: Bellenghi M; Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Puglisi R; Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Pedini F; Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., De Feo A; Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Felicetti F; Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Bottero L; Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Sangaletti S; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Errico MC; Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Petrini M; Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Gesumundo C; Department of Environment and Primary Prevention, Istituto Superiore di Sanità, Rome, Italy., Denaro M; Department of Environment and Primary Prevention, Istituto Superiore di Sanità, Rome, Italy., Felli N; Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Pasquini L; Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Tripodo C; Department of Health Sciences, University of Palermo, Italy., Colombo MP; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Carè A; Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Mattia G; Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Publikováno v: The Journal of pathology [J Pathol] 2015 Jul; Vol. 236 (3), pp. 315-25. Date of Electronic Publication: 2015 Apr 20.
Zobrazit plný text záznamu
10
Akademický článek
HOXB1 restored expression promotes apoptosis and differentiation in the HL60 leukemic cell line.
Autor: Petrini M; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore Sanità, Rome 00161, Italy., Felicetti F; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore Sanità, Rome 00161, Italy., Bottero L; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore Sanità, Rome 00161, Italy., Errico MC; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore Sanità, Rome 00161, Italy., Morsilli O; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore Sanità, Rome 00161, Italy., Boe A; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore Sanità, Rome 00161, Italy., De Feo A; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore Sanità, Rome 00161, Italy., Carè A; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore Sanità, Rome 00161, Italy.
Publikováno v: Cancer cell international [Cancer Cell Int] 2013 Oct 22; Vol. 13 (1), pp. 101. Date of Electronic Publication: 2013 Oct 22.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje